A phase II study of the anti-CTLA4 monoclonal antibody (mAb), CP-675,206, in patients with refractory metastatic adenocarcinoma of the colon or rectum No significant financial relationships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results